Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Association Between Rim Enhancement Of Breast Cancer On Dynamic Contrast-enhanced MRI And Patient Outcome: Impact Of Subtype

A. Schmitz, C. Loo, J. Wesseling, R. Pijnappel, K. Gilhuijs
Published 2014 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
The heterogeneous nature of breast cancer is represented by three breast cancer subtypes associated with different patient outcome. However, within subtypes, variations still exist. Additional stratification is necessary for more individualized therapy. Functional tumor characteristics on dynamic contrast-enhanced (DCE)-MRI may play a role. Rim enhancement of breast cancers has been associated with unfavorable pathology characteristics in the context of outcome. However, existence of a direct link is unknown. The purpose was to retrospectively determine the association between rim enhancement on DCE-MRI and long-term patient outcome, and whether it has complementary value to subtype. Preoperative DCE-MRI was performed in 556 consecutive female patients who were eligible for breast-conserving therapy. Presence of rim enhancement was assessed. Tumor characteristics were derived from resection specimens. Patients were stratified according to subtype. Association was assessed between rim enhancement and patient, pathology and treatment characteristics, recurrence-free interval and invasive disease-free survival. Median follow-up was 84 months. Patients were stratified into ER-positive/HER2-negative (N = 416), HER2-positive (N = 75), or triple-negative (N = 65) subtypes. Rim enhancement was seen in 29.0 % (N = 161/556) of tumors and was associated with higher histologic grade, negative ER-status, and triple-negative subtype. Only within triple-negative tumors, an association was seen with outcome. Recurrence was lower in non-rim-enhancing tumors (N = 1/36; 2.8 %) compared to rim-enhancing tumors (N = 9/28; 32.1 %) (p = 0.001). Survival was higher in non-rim-enhancing tumors (N = 34/36; 94.4 %) compared to rim-enhancing tumors (N = 18/28; 64.3 %) (p = 0.001). Rim enhancement on DCE-MRI is associated with long-term outcome of patients with triple-negative breast cancer and may potentially serve as a prognostic biomarker in these patients.
This paper references
A practical approach to manage additional lesions at preoperative breast MRI in patients eligible for breast conserving therapy: results
L. E. Elshof (2010)
Invasive breast cancer: correlation of dynamic MR features with prognostic factors
B. Szabó (2003)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T. Sørlie (2001)
Avoiding preoperative breast MRI when conventional imaging is sufficient to stage patients eligible for breast conserving therapy.
Kenneth E. Pengel (2014)
Descriptive analysis of estrogen receptor (ER)‐negative, progesterone receptor (PR)‐negative, and HER2‐negative invasive breast cancer, the so‐called triple‐negative phenotype
K. Bauer (2007)
Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis.
L. Buadu (1996)
Molecular portraits of human breast tumours
C. Perou (2000)
The American College of Radiology (ACR) Breast Imaging and Reporting Data System (BI-RADS): a step towards a universal radiological language?
D. Vanel (2007)
Trastuzumab--mechanism of action and use in clinical practice.
C. Hudis (2007)
The Presence of a Fibrotic Focus in Invasive Breast Carcinoma Correlates with the Expression of Carbonic Anhydrase IX and is a Marker of Hypoxia and Poor Prognosis
C. Colpaert (2004)
Correlation between numeric gadolinium-enhanced dynamic MRI ratios and prognostic factors and histologic type of breast carcinoma
成定 宏之 (2006)
Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system.
C. Hudis (2007)
Patterns of peripheral enhancement in breast masses: correlation of findings on contrast medium enhanced MRI with histologic features and tumor angiogenesis.
L. Buadu (1997)
Intratumoral hypoxia resulting in the presence of a fibrotic focus is an independent predictor of early distant relapse in lymph node‐negative breast cancer patients
C. Colpaert (2001)
Fibrotic focus in infiltrating ductal carcinoma of the breast: A significant histopathological prognostic parameter for predicting the long-term survival of the patients
T. Hasebe (2004)
Reduction in the number of sentinel lymph node procedures by preoperative ultrasonography of the axilla in breast cancer.
E. Deurloo (2003)
Multicentric breast carcinomas: Clinical-radiographic-pathologic whole organ studies and 10-year survival
H. Bingham (1982)
Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer.
C. Liedtke (2008)
Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence
R. Dent (2007)
Vascular endothelial growth factor as a target for anticancer therapy.
N. Ferrara (2004)
An individual person data meta-analysis of preoperative magnetic resonance imaging and breast cancer recurrence.
Nehmat Houssami (2014)
Triple-negative breast cancer: therapeutic options.
S. Cleator (2007)
Magnetic resonance imaging of breast cancer and correlation with prognostic factors
Y. Chang (2009)
Hypofractionation results in reduced tumor cell kill compared to conventional fractionation for tumors with regions of hypoxia.
D. Carlson (2011)
Gene expression profiles associated with the growth pattern and presence of a fibrotic focus in breast cancer
G. G. Eynden (2006)
Breast imaging reporting and data system (BI-RADS).
L. Liberman (2002)
Prognostic significance of Nottingham histologic grade in invasive breast carcinoma.
E. Rakha (2008)
Gene Expression Profiles Associated with the Presence of a Fibrotic Focus and the Growth Pattern in Lymph Node–Negative Breast Cancer
G. G. Van den Eynden (2008)
Breast masses with peripheral rim enhancement on dynamic contrast-enhanced MR images: correlation of MR findings with histologic features and expression of growth factors.
R. Matsubayashi (2000)
Correlation between High Resolution Dynamic MR Features and Prognostic Factors in Breast Cancer
S. Lee (2008)
Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype
Huang Jun (2014)
Is there different correlation with prognostic factors between "non-mass" and "mass" type invasive ductal breast cancers?
L. Jiang (2013)
Dynamic MR imaging of breast lesions: correlation with microvessel distribution pattern and histologic characteristics of prognosis.
A. Teifke (2006)

This paper is referenced by
Improved fat suppression of the breast using discretized frequency shimming
Tijl A. Velden (2018)
MR imaging features associated with distant metastasis-free survival of patients with invasive breast cancer: a case–control study
S. Song (2017)
Relating Doses of Contrast Agent Administered to TIC and Semi-Quantitative Parameters on DCE-MRI: Based on a Murine Breast Tumor Model
Menglin Wu (2016)
Usefulness of preoperative breast magnetic resonance imaging with a dedicated axillary sequence for the detection of axillary lymph node metastasis in patients with early ductal breast cancer
H. S. Ahn (2019)
Association between dynamic contrast enhanced MRI imaging features and WHO histopathological grade in patients with invasive ductal breast cancer.
J. Huang (2016)
Differentiation of triple-negative breast cancer from other subtypes through whole-tumor histogram analysis on multiparametric MR imaging
T. Xie (2018)
Association between MRI Features and Standardized Uptake Value of 18F-FDG PET/CT in Triple-Negative Breast Cancer
B. B. Choi (2018)
Imaging features associated with clinical outcome in breast cancer
J. Lee (2017)
Characterizing and eliminating errors in enhancement and subtraction artifacts in dynamic contrast‐enhanced breast MRI: Chemical shift artifact of the third kind
J. Derakhshan (2018)
Integration of imaging into clinical practice to assess the delivery and performance of macromolecular and nanotechnology-based oncology therapies.
Tara Spence (2015)
Valoración de los factores pronósticos radiopatológicos del cáncer de mama triple negativo y análisis del carcinoma in situ como factor pronóstico
C. Sebastián (2016)
Estimating B 1 + in the breast at 7 T using a generic template
Michael J van Rijssel (2018)
Imaging biomarkers of breast cancer derived from breast parenchyma
Jeffrey Wang (2017)
Associations between gene expression profiles of invasive breast cancer and Breast Imaging Reporting and Data System MRI lexicon
G. R. Kim (2017)
Added value of histogram analysis of apparent diffusion coefficient maps for differentiating triple-negative breast cancer from other subtypes of breast cancer on standard MRI
H. Liu (2019)
Identifying Triple-Negative Breast Cancer Using Background Parenchymal Enhancement Heterogeneity on Dynamic Contrast-Enhanced MRI: A Pilot Radiomics Study
J. Wang (2015)
Imaging and histologic prognostic factors in triple-negative breast cancer and carcinoma in situ as a prognostic factor.
C. Sebastián (2016)
Peritumoral edema as a biomarker of the aggressiveness of breast cancer: results of a retrospective study on a 3 T scanner
Giovanna Panzironi (2020)
Triple-negative breast cancer: Pretreatment magnetic resonance imaging features and clinicopathological factors associated with recurrence.
Youn Soo Lee (2019)
MR and mammographic imaging features of HER2-positive breast cancers according to hormone receptor status: a retrospective comparative study
S. Song (2017)
The association between MRI findings and breast cancer subtypes: focused on the combination patterns on diffusion-weighted and T2-weighted images
Sachiko Yuen (2020)
Spiküle Meme Kanserlerinin Histopatolojik Moleküler Biyobelirteçler ve Manyetik Rezonans Görüntüleme Arasındaki Korelasyonu
G. Gökalp (2020)
Fat suppression techniques for obtaining high resolution dynamic contrast enhanced bilateral breast MR images at 7T.
T. A. van der Velden (2016)
Can MRI Biomarkers Predict Triple-Negative Breast Cancer?
Giuliana Moffa (2020)
Pretreatment MR Imaging Features of Triple-Negative Breast Cancer: Association with Response to Neoadjuvant Chemotherapy and Recurrence-Free Survival.
M. Bae (2016)
MRI Radiomic Features: Association with Disease-Free Survival in Patients with Triple-Negative Breast Cancer
S. Kim (2020)
Magnetic resonance (MR) features in triple negative breast cancer (TNBC) vs receptor positive cancer (nTNBC).
Giulia Angelini (2018)
Biomarkers and Imaging of Breast Cancer.
Olena Weaver (2018)
Sonography with vertical orientation feature predicts worse disease outcome in triple negative breast cancer
Haoyu Wang (2019)
Machine Learning-Based Analysis of MR Multiparametric Radiomics for the Subtype Classification of Breast Cancer
T. Xie (2019)
Background parenchymal enhancement and fibroglandular tissue on breast MRI in women with high genetic risk: Are changes before and after risk-reducing salpingo-oophorectomy associated with breast cancer risk?
Cécile Bermot (2018)
Heterogeneous drug penetrance of veliparib and carboplatin measured in triple negative breast tumors
I. Bartelink (2017)
See more
Semantic Scholar Logo Some data provided by SemanticScholar